Granite Bay Wealth Management, LLC Sorrento Therapeutics, Inc. Transaction History

Granite Bay Wealth Management, LLC

  • $178 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 20, 2023
BUY
$0.17 - $1.19 $578 - $4,046
3,400 Added 17.78%
22,520 $8,000
Q4 2022

Jan 26, 2023
SELL
$0.74 - $1.83 $518 - $1,281
-700 Reduced 3.53%
19,120 $17,000
Q2 2022

Jul 13, 2022
SELL
$1.24 - $2.33 $372 - $699
-300 Reduced 1.49%
19,820 $40,000
Q1 2022

Apr 26, 2022
BUY
$2.0 - $4.9 $7,700 - $18,865
3,850 Added 23.66%
20,120 $47,000
Q4 2021

Feb 16, 2022
BUY
$4.65 - $7.23 $75,655 - $117,632
16,270 New
16,270 $76,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Granite Bay Wealth Management, LLC Portfolio

Follow Granite Bay Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Bay Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Bay Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email